ÂÜÀòÂÒÂ×

Stan Abel has a diverse work experience, primarily in executive roles within the biotechnology and pharmaceutical industries. Stan currently holds the position of President and Chief Executive Officer at ProJenX, Inc. starting in May 2022. Previously, from 2014 to 2020, they served as Chairman of the Board of Directors and later as Chief Executive Officer at SiteOne Therapeutics, Inc., where they led the development of novel pain management therapies.

Before their time at SiteOne Therapeutics, Inc., Stan worked as an independent consultant, serving as a Principal Consultant from 2013 to 2014. Prior to that, they were the Chief Business Officer at Sonexa Therapeutics, Inc. from 2010 to 2013.

Stan's leadership experience also includes their role as Chief Executive Officer at Corthera, Inc. from 2007 to 2010. Stan served as Chief Financial Officer at both Cerexa, Inc. from 2005 to 2007 and Peninsula Pharmaceuticals, Inc. from 2003 to 2005.

Earlier in their career, Stan worked in corporate finance at Eli Lilly and Company from 1998 to 2003.

Stan Abel obtained a Master of Business Administration (MBA) degree in Finance and Economics from The University of Chicago Booth School of Business. Stan attended this institution from 1995 to 1998. Prior to that, Stan had completed their Bachelor of Science (BS) degree in Business from Indiana University Bloomington, although the specific start and end years are not provided.